Cellebrite DI Ltd. (FRA:9W9)

Cellebrite DI Statistics

Total Valuation

Cellebrite DI has a market cap or net worth of EUR 3.88 billion. The enterprise value is 3.39 billion.

Market Cap	3.88B
Enterprise Value	3.39B

Important Dates

The next estimated earnings date is Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	244.47M
Shares Outstanding	n/a
Shares Change (YoY)	+22.84%
Shares Change (QoQ)	+0.30%
Owned by Insiders (%)	0.63%
Owned by Institutions (%)	46.49%
Float	120.89M

Valuation Ratios

The trailing PE ratio is 59.63 and the forward PE ratio is 34.81.

PE Ratio	59.63
Forward PE	34.81
PS Ratio	9.98
PB Ratio	10.17
P/TBV Ratio	11.13
P/FCF Ratio	32.46
P/OCF Ratio	29.81
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 49.93, with an EV/FCF ratio of 28.33.

EV / Earnings	52.05
EV / Sales	8.64
EV / EBITDA	49.93
EV / EBIT	64.15
EV / FCF	28.33

Financial Position

The company has a current ratio of 2.11, with a Debt / Equity ratio of 0.05.

Current Ratio	2.11
Quick Ratio	1.99
Debt / Equity	0.05
Debt / EBITDA	0.27
Debt / FCF	0.15
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 20.46% and return on invested capital (ROIC) is 9.84%.

Return on Equity (ROE)	20.46%
Return on Assets (ROA)	5.24%
Return on Invested Capital (ROIC)	9.84%
Return on Capital Employed (ROCE)	11.87%
Revenue Per Employee	332,962
Profits Per Employee	55,749
Employee Count	1,167
Asset Turnover	0.62
Inventory Turnover	7.96

Taxes

In the past 12 months, Cellebrite DI has paid 6.79 million in taxes.

Income Tax	6.79M
Effective Tax Rate	9.45%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	14.75
200-Day Moving Average	15.26
Relative Strength Index (RSI)	52.40
Average Volume (20 Days)	73

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.85

Income Statement

In the last 12 months, Cellebrite DI had revenue of EUR 388.57 million and earned 65.06 million in profits. Earnings per share was 0.27.

Revenue	388.57M
Gross Profit	326.26M
Operating Income	52.33M
Pretax Income	71.85M
Net Income	65.06M
EBITDA	61.41M
EBIT	52.33M
Earnings Per Share (EPS)	0.27

Balance Sheet

The company has 448.06 million in cash and 18.27 million in debt, with a net cash position of 489.09 million.

Cash & Cash Equivalents	448.06M
Total Debt	18.27M
Net Cash	489.09M
Net Cash Per Share	n/a
Equity (Book Value)	381.56M
Book Value Per Share	1.57
Working Capital	299.57M

Cash Flow

In the last 12 months, operating cash flow was 130.15 million and capital expenditures -10.61 million, giving a free cash flow of 119.54 million.

Operating Cash Flow	130.15M
Capital Expenditures	-10.61M
Free Cash Flow	119.54M
FCF Per Share	n/a

Margins

Gross margin is 83.96%, with operating and profit margins of 13.47% and 16.74%.

Gross Margin	83.96%
Operating Margin	13.47%
Pretax Margin	18.49%
Profit Margin	16.74%
EBITDA Margin	15.80%
EBIT Margin	13.47%
FCF Margin	30.76%

Dividends & Yields

Cellebrite DI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.84%
Shareholder Yield	-22.84%
Earnings Yield	1.68%
FCF Yield	3.08%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cellebrite DI has an Altman Z-Score of 7.67 and a Piotroski F-Score of 5.

Altman Z-Score	7.67
Piotroski F-Score	5